CurrentCardio coverage · page 8 of 11
JACC: Cardiovascular Interventions
Latest from JACC: Cardiovascular Interventions
JACC Cardiovasc Interv
Association of Baseline Tricuspid Regurgitation With Health Status and Clinical Outcomes After TAVR and Mitral TEER
Cohort studyValvular & structural
JACC Cardiovasc Interv
Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves
Cohort studyValvular & structural
JACC Cardiovasc Interv
Transjugular Transcatheter Tricuspid Valve Replacement: Early Compassionate Use Outcomes
Cohort studyValvular & structural
JACC Cardiovasc Interv
Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach: FAME 3 Trial
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
3-Year Outcomes of Balloon-Expandable Valves: 20-mm vs Larger Valves (≥23 mm)
Cohort studyValvular & structural
JACC Cardiovasc Interv
Diagnostic Performance of Fractional Flow Reserve Derived From Coronary CT Angiography: The ACCURATE-CT Study
Diagnostic or prognostic studyCoronary & ACS
JACC Cardiovasc Interv
Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion
Guideline or statementArrhythmias & EP
JACC Cardiovasc Interv
Prognostic Value of Coronary Angiography–Derived Index of Microcirculatory Resistance in Non–ST-Segment Elevation Myocardial Infarction Patients
Diagnostic or prognostic studyCoronary & ACS
JACC Cardiovasc Interv
Association Between Aortic Wall Thrombus and Thromboembolic Events After Transfemoral Transcatheter Aortic Valve Replacement
Cohort studyValvular & structural
JACC Cardiovasc Interv
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study
Cohort studyValvular & structural
JACC Cardiovasc Interv
Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion
Cohort studyArrhythmias & EP
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Staging Extramitral Cardiac Damage in Mitral Annular Calcification With Mitral Valve Dysfunction
Cohort studyValvular & structural
JACC Cardiovasc Interv
Performance of Purpose-Built vs Off-Label Transcatheter Devices for Aortic Regurgitation: The PURPOSE Study
Cohort studyValvular & structural
JACC Cardiovasc Interv
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Predicting Successful Chronic Total Occlusion Crossing With Primary Antegrade Wiring Using Machine Learning
Diagnostic or prognostic studyCoronary & ACS
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Guideline-Directed Medical Therapy and Survival After TEER for Secondary Mitral Regurgitation With Right Ventricular Impairment
Cohort studyValvular & structural
JACC Cardiovasc Interv
Performance of Transcatheter Direct Annuloplasty in Patients With Atrial and Nonatrial Functional Tricuspid Regurgitation
Cohort studyValvular & structural
JACC Cardiovasc Interv
Timing of Noncardiac Surgery Following Transcatheter Aortic Valve Replacement: A National Analysis
Cohort studyValvular & structural
JACC Cardiovasc Interv
Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty: The ULTIMATE Ⅲ Trial
Randomised controlled trialCoronary & ACS
JACC Cardiovasc Interv
Sex-Specific Differences in Upstream Cardiac Damage in Patients With Aortic Stenosis Undergoing TAVR
Cohort studyValvular & structural
JACC Cardiovasc Interv
Impact of Intravascular Imaging-Guided Stent Optimization According to Clinical Presentation in Patients Undergoing Complex PCI
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
A Randomized Controlled Trial of Nonfasting vs Fasting Before Interventional Coronary Procedures: The TONIC Trial
Randomised controlled trialCoronary & ACS
JACC Cardiovasc Interv
Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact
Cohort studyArrhythmias & EP
JACC Cardiovasc Interv
Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair
Cohort studyValvular & structural
JACC Cardiovasc Interv
QFR for the Revascularization of Nonculprit Vessels in MI Patients: Insights From the FIRE Trial
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves
Cohort studyValvular & structural
JACC Cardiovasc Interv
Real-World Outcomes of Carotid Artery Stenting in Symptomatic and Asymptomatic Patients With Carotid Artery Stenosis
Cohort studyAortic & peripheral
JACC Cardiovasc Interv
Unintended Deformation of Stents During Bifurcation PCI: An OCTOBER Trial Substudy
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
Transcatheter-Based Interventions for Tetralogy of Fallot Across All Age Groups
Research articleCongenital
JACC Cardiovasc Interv
Retrograde Coronary Chronic Total Occlusion Intervention (JR-CTO) Score: From the Japanese CTO-PCI Expert Registry
Diagnostic or prognostic studyCoronary & ACS
JACC Cardiovasc Interv
Pacing Using Cardiac Implantable Electric Device During TAVR: 10-Year Experience of a High-Volume Center
Cohort studyValvular & structural
JACC Cardiovasc Interv
Long-Term Impact of Cardiac Damage Following Transcatheter Aortic Valve Replacement
Cohort studyValvular & structural
JACC Cardiovasc Interv
2-Year Clinical and Echocardiography Follow-Up of Transcatheter Mitral Valve Replacement With the Transapical Intrepid System
Meta-analysisValvular & structural
JACC Cardiovasc Interv
New Approaches to Assessment and Management of Tricuspid Regurgitation Before Intervention
Research articleValvular & structural
JACC Cardiovasc Interv
Contemporary 1-Year Outcomes of Mitral Valve-in-Ring With Balloon-Expandable Aortic Transcatheter Valves in the U.S.
Cohort studyValvular & structural
JACC Cardiovasc Interv
Prognostic Value of Poststenting Fractional Flow Reserve After Imaging-Guided Optimal Stenting
Cohort studyCoronary & ACS